These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25191267)

  • 21. Global transcriptome analysis of Huperzia serrata and identification of critical genes involved in the biosynthesis of huperzine A.
    Yang M; You W; Wu S; Fan Z; Xu B; Zhu M; Li X; Xiao Y
    BMC Genomics; 2017 Mar; 18(1):245. PubMed ID: 28330463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
    Zhang HY; Tang XC
    Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease.
    Li X; Li W; Tian P; Tan T
    Biotechnol Adv; 2022 Nov; 60():108026. PubMed ID: 35914626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a better source of huperzine A than Huperzia serrata? Huperzine A content of Huperziaceae species in China.
    Ma X; Tan C; Zhu D; Gang DR
    J Agric Food Chem; 2005 Mar; 53(5):1393-8. PubMed ID: 15740012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel endophytic Huperzine A-producing fungus, Shiraia sp. Slf14, isolated from Huperzia serrata.
    Zhu D; Wang J; Zeng Q; Zhang Z; Yan R
    J Appl Microbiol; 2010 Oct; 109(4):1469-78. PubMed ID: 20602655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells.
    Tao Y; Fang L; Yang Y; Jiang H; Yang H; Zhang H; Zhou H
    Proteomics; 2013 Apr; 13(8):1314-24. PubMed ID: 23424162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
    Wang CY; Zheng W; Wang T; Xie JW; Wang SL; Zhao BL; Teng WP; Wang ZY
    Neuropsychopharmacology; 2011 Apr; 36(5):1073-89. PubMed ID: 21289607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research on endophytic fungi for producing huperzine A on a large-scale.
    Sang X; Yang M; Su J
    Crit Rev Microbiol; 2020 Nov; 46(6):654-664. PubMed ID: 32970952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease.
    Damar U; Gersner R; Johnstone JT; Schachter S; Rotenberg A
    Med Hypotheses; 2017 Feb; 99():57-62. PubMed ID: 28110700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined transcriptome and widely targeted metabolome analysis reveals the potential mechanism of HupA biosynthesis and antioxidant activity in
    Wu H; Shen Y; Zou F; Yao S; Chen Y; Yang H; Luo X
    Front Plant Sci; 2024; 15():1411471. PubMed ID: 38952843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
    Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
    J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models.
    Yan YP; Chen JY; Lu JH
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of huperzine a in the treatment of Alzheimer's disease.
    Desilets AR; Gickas JJ; Dunican KC
    Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneously preparative purification of Huperzine A and Huperzine B from Huperzia serrata by macroporous resin and preparative high performance liquid chromatography.
    Zhang H; Liang H; Kuang P; Yuan Q; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():65-72. PubMed ID: 22877738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huperzine A production by Paecilomyces tenuis YS-13, an endophytic fungus isolated from Huperzia serrata.
    Su J; Yang M
    Nat Prod Res; 2015; 29(11):1035-41. PubMed ID: 25427833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.
    Tripathi PN; Lodhi A; Rai SN; Nandi NK; Dumoga S; Yadav P; Tiwari AK; Singh SK; El-Shorbagi AA; Chaudhary S
    Degener Neurol Neuromuscul Dis; 2024; 14():47-74. PubMed ID: 38784601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
    Zhang HY; Yan H; Tang XC
    Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on huperzine A as a treatment for Alzheimer's disease.
    Little JT; Walsh S; Aisen PS
    Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease.
    Villegas C; Perez R; Petiz LL; Glaser T; Ulrich H; Paz C
    IUBMB Life; 2022 Aug; 74(8):763-779. PubMed ID: 35384262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.